html

2022 CDC Clinical Practice Guideline at a Glance | Overdose Prevention

What to know The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline) guides clinicians to work together with patients to make informed, patient-centered decisions about pain care. The 2022 Clinical Practice Guideline includes 12 recommendations for clinicians providing pain care for outpatients aged 18 years or older with acute […]

2022 CDC Clinical Practice Guideline at a Glance | Overdose Prevention Read More »

Opioid Use Among Adolescents & Young Adults: Toolkit for Pediatric & Primary Care Providers

DESCRIPTION
Item Number: SA5829

This toolkit has been developed specifically for pediatric, primary care, and other health professionals treating adolescents and young adults within their medical practice. It provides guidance in regard to the medical, psychological, and social needs of adolescents and young adults with opioid use disorders, thereby improving physical and mental health outcomes. It has been developed to help primary care and pediatric health providers advance the clinical interventions by offering developmentally appropriate screening, treatment engagement, and coordinated care. A specific focus on evidence-based practices includes Medication for Opioid Use Disorder (MOUD) guidance and resources to support these clinical interventions.

Opioid Use Among Adolescents & Young Adults: Toolkit for Pediatric & Primary Care Providers Read More »

U.S. Centers for Disease Control and Prevention Opioids Updating of CDC Opioid Prescribing Guideline

Process for Updating the Opioid Prescribing Guideline The draft 2022 CDC Clinical Practice Guideline for Prescribing Opioids was posted for a 60-day public comment period (from February 10, 2022 to April 11, 2022) in the Federal Register. It can be viewed here: https://www.federalregister.gov/documents/2022/02/10/2022-02802/proposed-2022-cdc-clinical-practice-guideline-for-prescribing-opioidsexternal icon

U.S. Centers for Disease Control and Prevention Opioids Updating of CDC Opioid Prescribing Guideline Read More »

U.S. Centers for Disease Control and Prevention Opioids

Safer Prescribing Saves Lives: Opioid Prescribing Guideline Chronic pain is common, multidimensional, and individualized. Treatment can be challenging for healthcare providers as well as patients. Since 1999, deaths involving prescription opioids have increased by more than five times, and over 200,000 people have died from prescription opioids.1 The recommendations in the CDC Guideline for Prescribing Opioids for

U.S. Centers for Disease Control and Prevention Opioids Read More »

Agency for Healthcare Research and Quality Opioids and Substance Use Disorder

Agency for Healthcare Research and Quality: A Profile The Agency for Healthcare Research and Quality (AHRQ) is the lead Federal agency charged with improving the safety and quality of healthcare for all Americans. AHRQ develops the knowledge, tools, and data needed to improve the healthcare system and help consumers, healthcare professionals, and policymakers make informed

Agency for Healthcare Research and Quality Opioids and Substance Use Disorder Read More »